QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL • US2197981051

23.58 USD
-0.16 (-0.65%)
At close: Feb 13, 2026
23.85 USD
+0.27 (+1.15%)
After Hours: 2/13/2026, 8:00:00 PM
Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 186 industry peers in the Health Care Equipment & Supplies industry. QDEL has a bad profitability rating. Also its financial health evaluation is rather negative. QDEL has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year QDEL was profitable.
  • QDEL had a positive operating cash flow in the past year.
  • In multiple years QDEL reported negative net income over the last 5 years.
  • Of the past 5 years QDEL 4 years had a positive operating cash flow.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

  • QDEL's Return On Assets of -20.78% is in line compared to the rest of the industry. QDEL outperforms 52.69% of its industry peers.
  • QDEL has a Return On Equity (-57.90%) which is in line with its industry peers.
  • The Return On Invested Capital of QDEL (1.74%) is better than 67.20% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 8.83%.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • With a decent Operating Margin value of 3.98%, QDEL is doing good in the industry, outperforming 67.74% of the companies in the same industry.
  • QDEL's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 47.15%, QDEL perfoms like the industry average, outperforming 41.94% of the companies in the same industry.
  • QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QDEL is destroying value.
  • There is no outstanding debt for QDEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • QDEL has an Altman-Z score of 0.72. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
  • QDEL has a Altman-Z score of 0.72. This is comparable to the rest of the industry: QDEL outperforms 51.61% of its industry peers.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that QDEL has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.23, QDEL is doing worse than 77.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.18
WACC9.65%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
  • QDEL has a worse Current ratio (1.78) than 66.67% of its industry peers.
  • QDEL has a Quick Ratio of 1.78. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • QDEL has a Quick ratio of 0.98. This is in the lower half of the industry: QDEL underperforms 75.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 14.59% over the past year.
  • The earnings per share for QDEL have been decreasing by -36.12% on average. This is quite bad
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.23%

3.2 Future

  • QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.97% yearly.
  • The Revenue is expected to grow by 3.50% on average over the next years.
EPS Next Y19.63%
EPS Next 2Y25.08%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue Next Year2.28%
Revenue Next 2Y3.23%
Revenue Next 3Y3.5%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

  • QDEL is valuated reasonably with a Price/Earnings ratio of 11.12.
  • Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 94.62% of the companies are valued more expensively.
  • QDEL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.97.
  • QDEL is valuated reasonably with a Price/Forward Earnings ratio of 9.30.
  • Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 95.16% of the companies in the same industry.
  • QDEL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 11.12
Fwd PE 9.3
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaper than 95.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.62
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as QDEL's earnings are expected to grow with 23.97% in the coming years.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y25.08%
EPS Next 3Y23.97%

0

5. Dividend

5.1 Amount

  • No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield 0%

QUIDELORTHO CORP

NASDAQ:QDEL (2/13/2026, 8:00:00 PM)

After market: 23.85 +0.27 (+1.15%)

23.58

-0.16 (-0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners123.47%
Inst Owner Change-1.26%
Ins Owners0.61%
Ins Owner Change1.31%
Market Cap1.60B
Revenue(TTM)N/A
Net Income(TTM)-1.18B
Analysts74.29
Price Target38.18 (61.92%)
Short Float %15.76%
Short Ratio10.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)1.55%
PT rev (3m)-6.82%
EPS NQ rev (1m)-20.18%
EPS NQ rev (3m)-44.52%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-1.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 11.12
Fwd PE 9.3
P/S 0.59
P/FCF N/A
P/OCF 42.94
P/B 0.79
P/tB N/A
EV/EBITDA 7.62
EPS(TTM)2.12
EY8.99%
EPS(NY)2.54
Fwd EY10.76%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY2.33%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.57
PEG (5Y)N/A
Graham Number37.81
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.72
F-Score5
WACC9.65%
ROIC/WACC0.18
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
EPS Next Y19.63%
EPS Next 2Y25.08%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.23%
Revenue Next Year2.28%
Revenue Next 2Y3.23%
Revenue Next 3Y3.5%
Revenue Next 5YN/A
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year940.25%
EBIT Next 3Y132.92%
EBIT Next 5Y90.11%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 7 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Undervalued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 11.12 and the Price/Book (PB) ratio is 0.79.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 19.63% in the next year.